Femme et Homme
- | Pays :
- Netherlands
- | Organes : -
- | Spécialités : -
Extrait
The main objective of this prospective clinical trial is to compare pharmacokinetics and safety and tolerability of a standard dose (400 mg) with an escalated dose (600 mg; 800 mg) of moxifloxacin (MFX). This clinical trial will provide important safety information on MFX in a higher dosage in TB patients.
Critère d'inclusion
- Tuberculosis